The agency has failed to consider ways in which industry influence can shape the patient voices that the FDA hears.

It’s worth taking the time to institute practices that ensure this money is used in ways that honor the tens of thousands of ...

Addiction science has produced practical, life-saving knowledge because federal research has been guided by rigorous peer ...

Housing First has a strong and extensive evidence base demonstrating that it improves housing stability. Findings on health outcomes and costs are mixed, although it is not clear whether this reflects ...

Addressing the physician and nurse shortages will require both upstream interventions that build a shared health career pipeline and downstream investments that expand the distinct training capacities ...

Congress should give employers a more accountable and affordable option to administer their medical benefit plans.

The advent of cell and gene therapies heralds a powerful shift, but without deliberate attention to financing, delivery, data ...

The concept rests on assumptions that are unsupported by evidence. Consequently, current proposals for mandatory ...

As HHS Secretary, Robert F. Kennedy Jr. has selectively cherry-picked many of his long-standing interests and their purported ...

Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee ...

The Trump administration is seeking changes that go beyond legal requirements. Institutional leaders must demand that any federal constraints on the pursuit of health equity be grounded in law.

The rapid growth of private equity (PE) and publicly traded corporation (PTC) ownership in hospice has raised concerns that investor-driven profit incentives may undermine care quality. Evidence on ...